After safety reviews, Oxford says there is insufficient evidence to say for certain that neurological symptoms developed by volunteers were or were not related to the vaccine.
Microbiologist from the University of Hong Kong, Yuen Kwok-yung, said the vaccine stimulates the natural infection pathway of respiratory viruses to activate the immune response.
AstraZeneca CEO Pascal Soriot sought to reassure investors after the Oxford vaccine trial was halted due to a person in the UK falling sick, triggering a review of safety data.
9 Covid vaccine developers signed a pledge saying they won't submit their inoculations for Food & Drug Administration approval until they show safety & efficacy in late-stage trial.
In the latest edition of its e-newsletter, ICMR has lauded its own efforts in bolstering India’s testing capacity, saying it ‘has broken the global perception’.
FDA's decision set off a media firestorm, with politicians, public-health officials & medical professionals insisting that the Trump administration was playing politics with science.
Cambridge University aims to use genetic sequences of other known coronaviruses to create one vaccine that goes beyond Covid-19 to fight related diseases.
Indian Council of Medical Research is in the process of developing an online vaccine portal which will provide information related to Covid-19 vaccine development in India and abroad.
CureVac, based in Tubingen, Germany, said in June that it received regulatory approval to begin Phase 1 trials of its vaccine candidate. It said it expects the results in the fourth quarter.
Just like Phase 3, in this round too, the NDA stands to lose ground due to the sheer number of seats it had won the last time — 39 of the 49 seats, of which the BJP alone had won 32.
India’s defence sector is trying to penetrate the African market. But with China already extending significant influence, India must now play catch-up.
Discussion about outcome of Lok Sabha polls continues to boil in cauldron of expectations only from BJP. Now reverse this equation, what if we asked about the performance of the 'loser'?
COMMENTS